Filing Details
- Accession Number:
- 0000950170-25-056445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-21 21:31:10
- Reporting Period:
- 2025-04-17
- Filing Date:
- 2025-04-21
- Accepted Time:
- 2025-04-21 21:31:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861107 | Ceribell Inc. | CBLL | Electromedical & Electrotherapeutic Apparatus (3845) | 471785452 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2035784 | Xingjuan Chao | C/O Ceribell, Inc. 360 N. Pastoria Avenue Sunnyvale CA 94085 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-17 | 5,700 | $15.02 | 746,451 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-04-21 | 3,372 | $15.03 | 743,079 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 369,088 | Indirect | By ACP 2021 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
- The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Billionaire Hedge Funds
